http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114569903-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30783f5e0439f26fb23d0089d47f0ea6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate | 2022-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b561d5bcd737a43bb7448c572409c20c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9153d067b4b5860e417d7f027d00f89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc4f856f657c64d7ce0411c8f4aa9628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c26a7ec47abdb73b976b5a750ee200c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54124170b323a4049b3e80d29cffc89c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3aea56a1924d9e6e65adaf9b420f1ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11f9ab3e3e679c1bd936c9b6dcc4fb5 |
| publicationDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114569903-A |
| titleOfInvention | In vitro non-invasive therapeutic apparatus for pulsed ultrasound synergistic drug and operation method thereof |
| abstract | The invention belongs to the technical field of medical equipment, and specifically discloses a pulsed ultrasonic synergistic drug in vitro non-invasive therapeutic apparatus and an operation method thereof, including an ultrasonic generation system, a drug monitoring system and a drug delivery system. The ultrasonic generation system includes an ultrasonic generator and an ultrasonic wave. The transducer, the ultrasonic transducer has a low-frequency range and a high-frequency range; the drug monitoring system is a reflective fluorescence imaging system, which detects the drug-loaded nanoparticle by collecting the fluorescent photons reflected by the drug-loaded nanoparticles marked with fluorescent substances in the skin tissue. The fluorescence intensity of the drug nanoparticles is used to monitor the enrichment degree of the drug in the lesion tissue of the treatment area; the drug delivery system is combined with the drug monitoring system to realize the precise and controlled release of the drug. This therapeutic apparatus integrates ultrasonic drug penetration and sonodynamic therapy, and realizes non-invasive in vitro treatment of tuberculosis lesions and precise drug delivery, high-efficiency controlled release, and high-efficiency sterilization through ultrasonic synergy with drugs, preventing the formation of drug-resistant tuberculosis bacteria or reversing drug resistance. . |
| priorityDate | 2022-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.